Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-027776
Filing Date
2025-03-25
Accepted
2025-03-25 16:07:38
Documents
1
Period of Report
2025-03-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2510055-6_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2510055-6_4seq1.xml 4 4165
  Complete submission text file 0001104659-25-027776.txt   5777
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Issuer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQ., BLDG. 1400E, STE.B14202 CAMBRIDGE MA 02139
Business Address
Milne Jill C. (Reporting) CIK: 0001644246 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 25768329